Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 9 | 2022 | 1260 | 2.120 |
Why?
|
| Antibodies, Neutralizing | 11 | 2025 | 303 | 1.980 |
Why?
|
| HIV Antibodies | 10 | 2022 | 247 | 1.770 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 2024 | 8 | 1.050 |
Why?
|
| Neutralization Tests | 3 | 2022 | 108 | 1.010 |
Why?
|
| AIDS Vaccines | 3 | 2022 | 152 | 0.930 |
Why?
|
| HIV Infections | 10 | 2022 | 5097 | 0.920 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 22 | 0.890 |
Why?
|
| Polymorphism, Genetic | 1 | 2024 | 99 | 0.860 |
Why?
|
| Spike Glycoprotein, Coronavirus | 6 | 2025 | 101 | 0.700 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2020 | 6 | 0.680 |
Why?
|
| Humans | 26 | 2025 | 14537 | 0.640 |
Why?
|
| Genes, Immunoglobulin | 2 | 2019 | 5 | 0.610 |
Why?
|
| Genomics | 5 | 2023 | 109 | 0.580 |
Why?
|
| Polysaccharides | 1 | 2017 | 45 | 0.530 |
Why?
|
| Antibodies, Viral | 3 | 2025 | 284 | 0.510 |
Why?
|
| Germ Cells | 2 | 2021 | 9 | 0.500 |
Why?
|
| Alleles | 4 | 2024 | 143 | 0.500 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2024 | 9 | 0.380 |
Why?
|
| Epidemiological Monitoring | 2 | 2022 | 45 | 0.360 |
Why?
|
| Immune Evasion | 2 | 2022 | 31 | 0.360 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2022 | 4 | 0.350 |
Why?
|
| Pandemics | 2 | 2022 | 296 | 0.310 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 231 | 0.300 |
Why?
|
| Female | 8 | 2025 | 9103 | 0.270 |
Why?
|
| Databases, Genetic | 3 | 2021 | 22 | 0.240 |
Why?
|
| Amino Acids | 2 | 2022 | 16 | 0.240 |
Why?
|
| Transcriptome | 1 | 2024 | 14 | 0.220 |
Why?
|
| Epitopes | 2 | 2022 | 97 | 0.220 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 142 | 0.220 |
Why?
|
| South Africa | 7 | 2025 | 7596 | 0.210 |
Why?
|
| Solvents | 1 | 2022 | 15 | 0.190 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2022 | 36 | 0.190 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2022 | 28 | 0.190 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 435 | 0.190 |
Why?
|
| Phylogeny | 3 | 2022 | 231 | 0.190 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2019 | 52 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2021 | 175 | 0.180 |
Why?
|
| Immunogenetics | 1 | 2021 | 2 | 0.180 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 253 | 0.170 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 5 | 0.160 |
Why?
|
| Computational Biology | 1 | 2020 | 44 | 0.160 |
Why?
|
| V(D)J Recombination | 1 | 2019 | 1 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2019 | 11 | 0.150 |
Why?
|
| Genitalia, Female | 1 | 2019 | 17 | 0.150 |
Why?
|
| HIV Envelope Protein gp160 | 1 | 2019 | 22 | 0.150 |
Why?
|
| Hospitalization | 1 | 2022 | 418 | 0.150 |
Why?
|
| Lysine | 1 | 2018 | 5 | 0.150 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2018 | 9 | 0.150 |
Why?
|
| Male | 3 | 2025 | 6754 | 0.150 |
Why?
|
| Vagina | 1 | 2019 | 91 | 0.150 |
Why?
|
| Antibody Formation | 1 | 2018 | 61 | 0.140 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2018 | 104 | 0.140 |
Why?
|
| Adult | 5 | 2025 | 5913 | 0.140 |
Why?
|
| Young Adult | 3 | 2025 | 2498 | 0.140 |
Why?
|
| Mutation | 3 | 2022 | 306 | 0.120 |
Why?
|
| Adolescent | 3 | 2025 | 2985 | 0.080 |
Why?
|
| Africa | 2 | 2022 | 376 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2022 | 84 | 0.080 |
Why?
|
| Middle Aged | 3 | 2025 | 3601 | 0.080 |
Why?
|
| Animals | 2 | 2022 | 1081 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2025 | 109 | 0.060 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 39 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2022 | 13 | 0.050 |
Why?
|
| Botswana | 1 | 2022 | 24 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2022 | 27 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2022 | 64 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 93 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2022 | 133 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 171 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2021 | 3 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2021 | 7 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 34 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 44 | 0.040 |
Why?
|
| Logistic Models | 1 | 2022 | 254 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2021 | 65 | 0.040 |
Why?
|
| Aged | 1 | 2025 | 1740 | 0.040 |
Why?
|
| Web Browser | 1 | 2020 | 1 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2019 | 10 | 0.040 |
Why?
|
| Software | 1 | 2020 | 37 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 10 | 0.040 |
Why?
|
| Reproductive Tract Infections | 1 | 2019 | 8 | 0.040 |
Why?
|
| VDJ Exons | 1 | 2019 | 1 | 0.040 |
Why?
|
| Gene Library | 1 | 2019 | 2 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 5 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2019 | 16 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 15 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2019 | 32 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2019 | 59 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 48 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 39 | 0.040 |
Why?
|
| Base Sequence | 1 | 2019 | 149 | 0.040 |
Why?
|
| Viremia | 1 | 2019 | 66 | 0.040 |
Why?
|
| Immunization | 1 | 2019 | 63 | 0.040 |
Why?
|
| Protein Binding | 1 | 2018 | 62 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2018 | 17 | 0.040 |
Why?
|
| Peptides | 1 | 2018 | 40 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 139 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 3 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2018 | 10 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 17 | 0.040 |
Why?
|
| RNA | 1 | 2018 | 26 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 60 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 42 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 260 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 303 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2022 | 1748 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 265 | 0.030 |
Why?
|
| Child | 1 | 2022 | 2242 | 0.030 |
Why?
|
| Viral Load | 1 | 2019 | 819 | 0.030 |
Why?
|